Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Oncolys BioPharma surges on European patent intention notice for endoscopic administration of OBP-301
Oncolys BioPharma Inc. <4588> rebounded sharply. After the market close on May 27, the company announced it received a notice of intention to grant a patent from the European Patent Office (EPO) for the endoscopic administration of its pipeline oncolytic virus candidate OBP-301, a disclosure that attracted buying interest. The notice indicates the EPO's decision to grant a European patent based on the current application. Following the approval, ONCOLYS plans to expand its patent protection network, targeting major European markets including the United Kingdom, France, and Germany.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
South Korean KOSPI opens at 8,165.73 on the 28th, down 62.97 points
Singapore Nikkei 225 futures open at 65,035 yen on the 28th, down 20 yen
U.S. stocks overview on the 27th: Dow Jones up 182 points, reaching record highs with Nasdaq
U.S. forex market summary: dollar rises to 159.50 yen level amid Middle East uncertainty
Alfresa Holdings rises for third day on plan to acquire medical device maker Nagashima Medical Instruments
Tokyo stocks seen firm on May 28 as falling crude oil prices provide support
AI revolution and dangerous scent of polarized market ahead
Oricon, Postponed Dividend for This Fiscal Year
ITO EN, Ordinary Profit Forecast for Last Fiscal Year Revised Upward to an Unexpected 1% Increase
BlueMeme, Ordinary Profit Forecast for Last Fiscal Year Revised Downward by 13%